Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
collection:"CTG"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22ulcerative+colitis.%22&type=Subject&filter%5B%5D=collection%3ACTG
/vufind/Search/Results?lookfor=%22ulcerative+colitis.%22&type=Subject&filter%5B%5D=collection%3ACTG
Search /vufind/Search2/Results?lookfor=%22ulcerative+colitis.%22&type=Subject&filter%5B%5D=collection%3ACTG
PubPharm (6.097)
1
Comparison of Two Different Golimumab Dosing Regimens for Ulcerative Colitis : Exposure-response of golimumab during maintenance in ulcerative colitis: An exploratory Pharmacokinetics/Pharmacodynamics comparison of different dose regimens
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
A Study to Evaluate the Safety and Efficacy of the Ustekinumab Induction and Maintenance Therapy in Participants with Moderately to Severely Active Ulcerative Colitis : A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis - UNIFI
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
A study evaluating the efficacy and safety of Etrasimod in the treatment of patients with moderately to severely active Ulcerative Colitis : A Phase 3, Randomized, Double Blind, Placebo Controlled, 12 Week Study to Assess the Efficacy and Safety of Etrasimod in Subjects with Moderately to Severely Active Ulcerative Colitis - ELEVATE UC 12
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
BI 655130 induction treatment in patients with moderate-tosevere ulcerative colitis : A Phase II/III Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Safety and Efficacy of BI 655130 Induction Therapy in patients with moderate-to-severely active ulcerative colitis who have failed previous biologics therapy
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
Research study to determine whether an investigational drug, SHP647, is safe and effective in the treatment of moderate to severe Ulcerative Colitis, compared with placebo (dummy treatment) – using a randomised and blinded study design (investigator and patients are not aware whether they receive study drug or placebo)(FIGARO UC 303). : A Phase 3 Randomized, Double-blind, Placebo controlled, Parallel group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303) - FIGARO UC 303
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
A Study of the Efficacy and Safety of Guselkumab in Participants with Moderately to Severely Active Ulcerative Colitis : A Phase 2b/3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Efficacy and Safety of Guselkumab in Participants with Moderately to Severely Active Ulcerative Colitis - QUASAR
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
BI 655130 long-term treatment in patients with moderate-to-severe ulcerative colitis : An open label, long term safety trial of BI 655130 treatment in patients with moderate to severely active ulcerative colitis who have completed previous BI 655130 trials
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
A Pharmacokinetic, Pharmacodynamic, and Safety Study of Etrolizumab Followed by Open-Label Extension and Safety Monitoring in Pediatric Patients From 4 Years to Less Than 18 Years of Age with Moderate to Severe Ulcerative Colitis or Moderate to Severe Crohn’s Disease : A PHASE I, OPEN–LABEL, RANDOMIZED, PHARMACOKINETIC, PHARMACODYNAMIC, AND SAFETY STUDY OF ETROLIZUMAB FOLLOWED BY OPEN–LABEL EXTENSION AND SAFETY MONITORING IN PEDIATRIC PATIENTS FROM 4 YEARS TO LESS THAN 18 YEARS OF AGE WITH MODERATE TO SEVERE ULCERATIVE COLITIS OR MODERATE TO SEVERE CROHN’S DISEASE
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
Clinical Trial to evaluate the safety and efficacy of oral treatment with OST-122 in patients with moderate to severe ulcerative colitis : A Phase Ib/IIa, randomized, double blind, placebo controlled, multicenter clinical trial to evaluate the safety, pharmacokinetics and efficacy of oral treatment with OST-122 in patients with moderate to severe ulcerative colitis
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
Study of efficacy, safety and tolerability of LYS006 in patients with mild to moderate ulcerative colitis : A randomized, multi-center, subject and investigator blinded, placebo controlled, parallel group study to assess the efficacy, safety and tolerability of LYS006 in patients with mild to moderate ulcerative colitis - NA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[610]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
6.097
Aufsätze
6.097
E-Artikel
6.097
E-Ressourcen
Zeitschriftentitel
5.366
WHO International Clinical Trials Registry Plat...
731
ClinicalTrials.gov
Thema
6.097
610
5.256
Study Type: Interventional
2.830
Recruitment Status: Not yet recruiting
1.536
Phase: Phase 3
1.286
Phase: Phase 2
976
Recruitment Status: Authorised-recruitment may ...
762
Recruitment Status: Completed
725
Study Type: Observational
696
Colitis, Ulcerative
688
Recruitment Status: Recruiting
581
Colitis
566
Ulcer
538
Medical Condition: Ulcerative Colitis
372
Recruitment Status: Complete: follow-up complete
348
Medical Condition: Ulcerative colitis
272
Medical Condition: ulcerative colitis
228
Phase: Phase 4
218
Crohn Disease
204
Medical Condition: Ulcerative Colitis MedDRA ve...
176
Medical Condition: Ulcerative colitis MedDRA ve...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
3.600
2020-
2.468
2010-2019
29
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
6.037
Englisch
34
Unbestimmt
12
Spanisch
4
Niederländisch
4
Latein
2
Afrikaans
2
Finnisch
2
Indonesisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...